A Phase 3, Multicenter, Prospective, Randomized, Open-label Study for Intraoperative Ureter(s) Visualization When Using ASP5354 With Near Infrared Fluorescence (NIR-F) Imaging in Participants Undergoing Minimally Invasive and Open Abdominopelvic Surgeries
Latest Information Update: 04 Feb 2025
At a glance
- Drugs Pudexacianinium (Primary)
- Indications Intraoperative complications
- Focus Diagnostic use; Registrational
- Sponsors Astellas Pharma Global Development
Most Recent Events
- 30 Jan 2025 Status changed from active, no longer recruiting to completed.
- 10 Jan 2025 Status changed from recruiting to active, no longer recruiting.
- 18 Oct 2024 Planned End Date changed from 31 Oct 2024 to 31 Dec 2024.